nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC22A3—Irinotecan—lung cancer	0.307	1	CbGbCtD
Melphalan—SLC22A3—Organic cation transport—SLC22A18—lung cancer	0.0154	0.1	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCG2—lung cancer	0.011	0.0713	CbGpPWpGaD
Melphalan—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0104	0.068	CbGpPWpGaD
Melphalan—SLC7A5—mammary gland—lung cancer	0.00848	0.197	CbGeAlD
Melphalan—Chlorambucil—GSTP1—lung cancer	0.00771	0.715	CrCbGaD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCB1—lung cancer	0.00683	0.0445	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—PPIA—lung cancer	0.00633	0.0412	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCG2—lung cancer	0.00629	0.041	CbGpPWpGaD
Melphalan—SLC7A5—respiratory system—lung cancer	0.00565	0.131	CbGeAlD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00551	0.0359	CbGpPWpGaD
Melphalan—SLC7A5—epithelium—lung cancer	0.00472	0.11	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—GSTA2—lung cancer	0.00468	0.0305	CbGpPWpGaD
Melphalan—SLC7A5—bronchus—lung cancer	0.00465	0.108	CbGeAlD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SYP—lung cancer	0.00429	0.0279	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—UGT1A1—lung cancer	0.0042	0.0274	CbGpPWpGaD
Melphalan—SLC7A5—trachea—lung cancer	0.00418	0.0969	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—AHR—lung cancer	0.00409	0.0266	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NFE2L2—lung cancer	0.00398	0.0259	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—ITGB1—lung cancer	0.00393	0.0256	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCB1—lung cancer	0.00393	0.0256	CbGpPWpGaD
Melphalan—SLC7A5—cardiac atrium—lung cancer	0.00392	0.091	CbGeAlD
Melphalan—SLC7A5—bone marrow—lung cancer	0.00331	0.0768	CbGeAlD
Melphalan—SLC7A5—Basigin interactions—MMP1—lung cancer	0.00306	0.0199	CbGpPWpGaD
Melphalan—SLC7A5—lung—lung cancer	0.003	0.0696	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NQO1—lung cancer	0.00288	0.0188	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	0.00286	0.0186	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00246	0.016	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.00222	0.0145	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PPIA—lung cancer	0.00211	0.0137	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.00209	0.0136	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00209	0.0136	CbGpPWpGaD
Melphalan—SLC7A5—lymph node—lung cancer	0.00205	0.0476	CbGeAlD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00187	0.0122	CbGpPWpGaD
Melphalan—SLC22A3—lung—lung cancer	0.00186	0.0432	CbGeAlD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGB1—lung cancer	0.00131	0.00851	CbGpPWpGaD
Melphalan—SLC22A3—lymph node—lung cancer	0.00127	0.0295	CbGeAlD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00125	0.00817	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00125	0.00815	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.00115	0.00751	CbGpPWpGaD
Melphalan—Ibuprofen—UGT1A1—lung cancer	0.00114	0.106	CrCbGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.00112	0.00731	CbGpPWpGaD
Melphalan—Ibuprofen—CXCL8—lung cancer	0.00107	0.0996	CrCbGaD
Melphalan—SLC7A5—Hemostasis—KIF5B—lung cancer	0.00105	0.00687	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.00103	0.00674	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MMP1—lung cancer	0.00102	0.00662	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.00101	0.00655	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00095	0.00619	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000948	0.00618	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	0.000882	0.00574	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KDM1A—lung cancer	0.000866	0.00564	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CD9—lung cancer	0.000726	0.00473	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—lung cancer	0.00068	0.00443	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000637	0.00415	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—FGR—lung cancer	0.000629	0.0041	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GNG11—lung cancer	0.000595	0.00387	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—AVP—lung cancer	0.000587	0.00382	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PPIA—lung cancer	0.000571	0.00372	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000568	0.0037	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFC—lung cancer	0.000566	0.00369	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALDOA—lung cancer	0.000566	0.00369	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SRC—lung cancer	0.000545	0.00355	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—NRAS—lung cancer	0.000524	0.00341	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PPP2R1B—lung cancer	0.000521	0.0034	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GNG11—lung cancer	0.000515	0.00335	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TF—lung cancer	0.000497	0.00324	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IRF1—lung cancer	0.000487	0.00317	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000483	0.00315	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000463	0.00302	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000463	0.00302	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—KRAS—lung cancer	0.000451	0.00294	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—APP—lung cancer	0.000443	0.00289	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TF—lung cancer	0.00043	0.0028	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—lung cancer	0.000415	0.0027	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—HRAS—lung cancer	0.000384	0.0025	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—lung cancer	0.000356	0.00232	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ITGB1—lung cancer	0.000354	0.00231	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AZIN2—lung cancer	0.000326	0.00213	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—COL4A3BP—lung cancer	0.000326	0.00213	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—lung cancer	0.000313	0.0291	CrCbGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—AVP—lung cancer	0.000299	0.00195	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AVP—lung cancer	0.000298	0.00194	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000289	0.00188	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000289	0.00188	CbGpPWpGaD
Melphalan—Ibuprofen—ALB—lung cancer	0.000279	0.0259	CrCbGaD
Melphalan—SLC22A3—Metabolism—ATP5H—lung cancer	0.000278	0.00181	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MMP1—lung cancer	0.000276	0.00179	CbGpPWpGaD
Melphalan—Ibuprofen—ABCB1—lung cancer	0.000266	0.0247	CrCbGaD
Melphalan—SLC7A5—Hemostasis—APOA1—lung cancer	0.000264	0.00172	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000262	0.00171	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLBD1—lung cancer	0.000247	0.00161	CbGpPWpGaD
Melphalan—Infection—Cisplatin—lung cancer	0.000245	0.000505	CcSEcCtD
Melphalan—Vomiting—Topotecan—lung cancer	0.000245	0.000504	CcSEcCtD
Melphalan—Paraesthesia—Irinotecan—lung cancer	0.000244	0.000503	CcSEcCtD
Melphalan—Leukopenia—Paclitaxel—lung cancer	0.000243	0.000501	CcSEcCtD
Melphalan—Rash—Topotecan—lung cancer	0.000243	0.0005	CcSEcCtD
Melphalan—Hypersensitivity—Vinorelbine—lung cancer	0.000243	0.0005	CcSEcCtD
Melphalan—Dermatitis—Topotecan—lung cancer	0.000243	0.0005	CcSEcCtD
Melphalan—Vomiting—Erlotinib—lung cancer	0.000242	0.000499	CcSEcCtD
Melphalan—Dyspnoea—Irinotecan—lung cancer	0.000242	0.000499	CcSEcCtD
Melphalan—Cough—Etoposide—lung cancer	0.000242	0.000498	CcSEcCtD
Melphalan—Thrombocytopenia—Cisplatin—lung cancer	0.000242	0.000498	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000241	0.000497	CcSEcCtD
Melphalan—Tachycardia—Cisplatin—lung cancer	0.000241	0.000496	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CG—lung cancer	0.000241	0.00157	CbGpPWpGaD
Melphalan—Rash—Erlotinib—lung cancer	0.00024	0.000495	CcSEcCtD
Melphalan—Dermatitis—Erlotinib—lung cancer	0.00024	0.000494	CcSEcCtD
Melphalan—Convulsion—Etoposide—lung cancer	0.00024	0.000494	CcSEcCtD
Melphalan—Skin disorder—Cisplatin—lung cancer	0.00024	0.000494	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—lung cancer	0.00024	0.000493	CcSEcCtD
Melphalan—Dyspepsia—Irinotecan—lung cancer	0.000239	0.000493	CcSEcCtD
Melphalan—Immune system disorder—Docetaxel—lung cancer	0.000239	0.000492	CcSEcCtD
Melphalan—Mediastinal disorder—Docetaxel—lung cancer	0.000238	0.000491	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—EGF—lung cancer	0.000238	0.00155	CbGpPWpGaD
Melphalan—Paraesthesia—Gemcitabine—lung cancer	0.000238	0.00049	CcSEcCtD
Melphalan—Cough—Paclitaxel—lung cancer	0.000237	0.000488	CcSEcCtD
Melphalan—Asthenia—Vinorelbine—lung cancer	0.000236	0.000487	CcSEcCtD
Melphalan—Decreased appetite—Irinotecan—lung cancer	0.000236	0.000487	CcSEcCtD
Melphalan—Arrhythmia—Docetaxel—lung cancer	0.000236	0.000487	CcSEcCtD
Melphalan—Dyspnoea—Gemcitabine—lung cancer	0.000236	0.000486	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000236	0.00154	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000236	0.00154	CbGpPWpGaD
Melphalan—Chest pain—Etoposide—lung cancer	0.000236	0.000486	CcSEcCtD
Melphalan—Nausea—Vinblastine—lung cancer	0.000236	0.000485	CcSEcCtD
Melphalan—Convulsion—Paclitaxel—lung cancer	0.000235	0.000485	CcSEcCtD
Melphalan—Anorexia—Cisplatin—lung cancer	0.000235	0.000484	CcSEcCtD
Melphalan—Gastrointestinal disorder—Irinotecan—lung cancer	0.000235	0.000483	CcSEcCtD
Melphalan—Fatigue—Irinotecan—lung cancer	0.000234	0.000483	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000234	0.000482	CcSEcCtD
Melphalan—Alopecia—Docetaxel—lung cancer	0.000234	0.000481	CcSEcCtD
Melphalan—Pruritus—Vinorelbine—lung cancer	0.000233	0.00048	CcSEcCtD
Melphalan—Pain—Irinotecan—lung cancer	0.000232	0.000479	CcSEcCtD
Melphalan—Chest pain—Paclitaxel—lung cancer	0.000231	0.000476	CcSEcCtD
Melphalan—Myalgia—Paclitaxel—lung cancer	0.000231	0.000476	CcSEcCtD
Melphalan—Hypotension—Cisplatin—lung cancer	0.000231	0.000475	CcSEcCtD
Melphalan—Decreased appetite—Gemcitabine—lung cancer	0.00023	0.000474	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00023	0.000473	CcSEcCtD
Melphalan—Nausea—Topotecan—lung cancer	0.000229	0.000471	CcSEcCtD
Melphalan—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000229	0.000471	CcSEcCtD
Melphalan—Fatigue—Gemcitabine—lung cancer	0.000228	0.00047	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOA1—lung cancer	0.000228	0.00149	CbGpPWpGaD
Melphalan—Cardiac arrest—Doxorubicin—lung cancer	0.000227	0.000467	CcSEcCtD
Melphalan—Pain—Gemcitabine—lung cancer	0.000226	0.000466	CcSEcCtD
Melphalan—Nausea—Erlotinib—lung cancer	0.000226	0.000466	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HSD17B10—lung cancer	0.000226	0.00147	CbGpPWpGaD
Melphalan—Pancytopenia—Methotrexate—lung cancer	0.000226	0.000466	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—lung cancer	0.000226	0.000466	CcSEcCtD
Melphalan—Diarrhoea—Vinorelbine—lung cancer	0.000225	0.000464	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000225	0.000463	CcSEcCtD
Melphalan—Infection—Etoposide—lung cancer	0.000225	0.000463	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CREBBP—lung cancer	0.000223	0.00145	CbGpPWpGaD
Melphalan—Neutropenia—Methotrexate—lung cancer	0.000223	0.000459	CcSEcCtD
Melphalan—Oedema—Paclitaxel—lung cancer	0.000222	0.000457	CcSEcCtD
Melphalan—Anaphylactic shock—Paclitaxel—lung cancer	0.000222	0.000457	CcSEcCtD
Melphalan—Paraesthesia—Cisplatin—lung cancer	0.000222	0.000456	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—lung cancer	0.000221	0.000456	CcSEcCtD
Melphalan—Tachycardia—Etoposide—lung cancer	0.000221	0.000454	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—lung cancer	0.00022	0.000454	CcSEcCtD
Melphalan—Infection—Paclitaxel—lung cancer	0.00022	0.000454	CcSEcCtD
Melphalan—Dyspnoea—Cisplatin—lung cancer	0.00022	0.000453	CcSEcCtD
Melphalan—Skin disorder—Etoposide—lung cancer	0.00022	0.000452	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TF—lung cancer	0.000219	0.00143	CbGpPWpGaD
Melphalan—Thrombocytopenia—Paclitaxel—lung cancer	0.000217	0.000447	CcSEcCtD
Melphalan—Tachycardia—Paclitaxel—lung cancer	0.000216	0.000446	CcSEcCtD
Melphalan—Anorexia—Etoposide—lung cancer	0.000215	0.000444	CcSEcCtD
Melphalan—Skin disorder—Paclitaxel—lung cancer	0.000215	0.000443	CcSEcCtD
Melphalan—Decreased appetite—Cisplatin—lung cancer	0.000215	0.000442	CcSEcCtD
Melphalan—Gastrointestinal disorder—Cisplatin—lung cancer	0.000213	0.000439	CcSEcCtD
Melphalan—Anaemia—Docetaxel—lung cancer	0.000213	0.000438	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CD—lung cancer	0.000212	0.00138	CbGpPWpGaD
Melphalan—Anorexia—Paclitaxel—lung cancer	0.000211	0.000435	CcSEcCtD
Melphalan—Hypotension—Etoposide—lung cancer	0.000211	0.000435	CcSEcCtD
Melphalan—Pain—Cisplatin—lung cancer	0.000211	0.000435	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CKB—lung cancer	0.00021	0.00137	CbGpPWpGaD
Melphalan—Vomiting—Vinorelbine—lung cancer	0.00021	0.000432	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ALB—lung cancer	0.000209	0.00136	CbGpPWpGaD
Melphalan—Rash—Vinorelbine—lung cancer	0.000208	0.000428	CcSEcCtD
Melphalan—Dermatitis—Vinorelbine—lung cancer	0.000208	0.000428	CcSEcCtD
Melphalan—Hypotension—Paclitaxel—lung cancer	0.000207	0.000427	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—lung cancer	0.000207	0.000426	CcSEcCtD
Melphalan—Leukopenia—Docetaxel—lung cancer	0.000206	0.000424	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—lung cancer	0.000203	0.000418	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000202	0.000416	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—lung cancer	0.000202	0.000415	CcSEcCtD
Melphalan—Cough—Docetaxel—lung cancer	0.000201	0.000414	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—lung cancer	0.000201	0.000414	CcSEcCtD
Melphalan—Hypersensitivity—Irinotecan—lung cancer	0.0002	0.000412	CcSEcCtD
Melphalan—Convulsion—Docetaxel—lung cancer	0.000199	0.000411	CcSEcCtD
Melphalan—Paraesthesia—Paclitaxel—lung cancer	0.000199	0.00041	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTM2—lung cancer	0.000198	0.00129	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CNDP2—lung cancer	0.000198	0.00129	CbGpPWpGaD
Melphalan—Dyspnoea—Paclitaxel—lung cancer	0.000198	0.000407	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—lung cancer	0.000197	0.000405	CcSEcCtD
Melphalan—Chest pain—Docetaxel—lung cancer	0.000196	0.000404	CcSEcCtD
Melphalan—Myalgia—Docetaxel—lung cancer	0.000196	0.000404	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—lung cancer	0.000196	0.000403	CcSEcCtD
Melphalan—Nausea—Vinorelbine—lung cancer	0.000196	0.000403	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—lung cancer	0.000195	0.000402	CcSEcCtD
Melphalan—Dyspepsia—Paclitaxel—lung cancer	0.000195	0.000402	CcSEcCtD
Melphalan—Asthenia—Irinotecan—lung cancer	0.000195	0.000402	CcSEcCtD
Melphalan—Fatigue—Etoposide—lung cancer	0.000195	0.000401	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000195	0.000401	CcSEcCtD
Melphalan—Pain—Etoposide—lung cancer	0.000193	0.000398	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000193	0.00126	CbGpPWpGaD
Melphalan—Neutropenia—Doxorubicin—lung cancer	0.000193	0.000397	CcSEcCtD
Melphalan—Decreased appetite—Paclitaxel—lung cancer	0.000193	0.000397	CcSEcCtD
Melphalan—SLC22A3—Metabolism—MTMR3—lung cancer	0.000192	0.00125	CbGpPWpGaD
Melphalan—Haemoglobin—Methotrexate—lung cancer	0.000192	0.000395	CcSEcCtD
Melphalan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000191	0.000394	CcSEcCtD
Melphalan—Fatigue—Paclitaxel—lung cancer	0.000191	0.000394	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—lung cancer	0.000191	0.000393	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—lung cancer	0.000191	0.000393	CcSEcCtD
Melphalan—Asthenia—Gemcitabine—lung cancer	0.00019	0.000391	CcSEcCtD
Melphalan—Pain—Paclitaxel—lung cancer	0.00019	0.00039	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RAF1—lung cancer	0.000189	0.00123	CbGpPWpGaD
Melphalan—Urinary tract disorder—Methotrexate—lung cancer	0.000188	0.000388	CcSEcCtD
Melphalan—Oedema—Docetaxel—lung cancer	0.000188	0.000387	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—lung cancer	0.000188	0.000387	CcSEcCtD
Melphalan—SLC22A3—Metabolism—PGAM1—lung cancer	0.000187	0.00122	CbGpPWpGaD
Melphalan—Pruritus—Gemcitabine—lung cancer	0.000187	0.000386	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—lung cancer	0.000187	0.000385	CcSEcCtD
Melphalan—Infection—Docetaxel—lung cancer	0.000187	0.000384	CcSEcCtD
Melphalan—Diarrhoea—Irinotecan—lung cancer	0.000186	0.000383	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CB—lung cancer	0.000184	0.0012	CbGpPWpGaD
Melphalan—Thrombocytopenia—Docetaxel—lung cancer	0.000184	0.000379	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—lung cancer	0.000183	0.000378	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—lung cancer	0.000182	0.000376	CcSEcCtD
Melphalan—Hypersensitivity—Cisplatin—lung cancer	0.000182	0.000374	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—lung cancer	0.000181	0.00118	CbGpPWpGaD
Melphalan—Diarrhoea—Gemcitabine—lung cancer	0.000181	0.000373	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—lung cancer	0.000181	0.00118	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Doxorubicin—lung cancer	0.00018	0.000371	CcSEcCtD
Melphalan—Urticaria—Etoposide—lung cancer	0.00018	0.00037	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—lung cancer	0.000179	0.000369	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—lung cancer	0.000179	0.000369	CcSEcCtD
Melphalan—Anorexia—Docetaxel—lung cancer	0.000179	0.000369	CcSEcCtD
Melphalan—SLC22A3—Metabolism—CYP2A7—lung cancer	0.000179	0.00116	CbGpPWpGaD
Melphalan—Asthenia—Cisplatin—lung cancer	0.000177	0.000365	CcSEcCtD
Melphalan—Urticaria—Paclitaxel—lung cancer	0.000176	0.000363	CcSEcCtD
Melphalan—Hypotension—Docetaxel—lung cancer	0.000176	0.000362	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SDC4—lung cancer	0.000175	0.00114	CbGpPWpGaD
Melphalan—Hepatobiliary disease—Doxorubicin—lung cancer	0.000174	0.000358	CcSEcCtD
Melphalan—Vomiting—Irinotecan—lung cancer	0.000173	0.000356	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—lung cancer	0.000172	0.000355	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—lung cancer	0.000172	0.000354	CcSEcCtD
Melphalan—Rash—Irinotecan—lung cancer	0.000171	0.000353	CcSEcCtD
Melphalan—Dermatitis—Irinotecan—lung cancer	0.000171	0.000353	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000171	0.000353	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IL2—lung cancer	0.000169	0.0011	CbGpPWpGaD
Melphalan—Diarrhoea—Cisplatin—lung cancer	0.000169	0.000348	CcSEcCtD
Melphalan—Paraesthesia—Docetaxel—lung cancer	0.000169	0.000347	CcSEcCtD
Melphalan—Alopecia—Methotrexate—lung cancer	0.000168	0.000347	CcSEcCtD
Melphalan—Vomiting—Gemcitabine—lung cancer	0.000168	0.000347	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—lung cancer	0.000167	0.000345	CcSEcCtD
Melphalan—Rash—Gemcitabine—lung cancer	0.000167	0.000344	CcSEcCtD
Melphalan—Dermatitis—Gemcitabine—lung cancer	0.000167	0.000343	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—lung cancer	0.000167	0.000343	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—lung cancer	0.000166	0.000342	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—lung cancer	0.000165	0.000341	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—lung cancer	0.000165	0.00034	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—lung cancer	0.000165	0.00034	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—RAF1—lung cancer	0.000163	0.00106	CbGpPWpGaD
Melphalan—Decreased appetite—Docetaxel—lung cancer	0.000163	0.000336	CcSEcCtD
Melphalan—Hypersensitivity—Paclitaxel—lung cancer	0.000163	0.000336	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—lung cancer	0.000163	0.000336	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—lung cancer	0.000162	0.000334	CcSEcCtD
Melphalan—Asthenia—Etoposide—lung cancer	0.000162	0.000334	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—lung cancer	0.000162	0.000334	CcSEcCtD
Melphalan—Fatigue—Docetaxel—lung cancer	0.000162	0.000334	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—lung cancer	0.000162	0.000333	CcSEcCtD
Melphalan—Nausea—Irinotecan—lung cancer	0.000161	0.000332	CcSEcCtD
Melphalan—Pain—Docetaxel—lung cancer	0.000161	0.000331	CcSEcCtD
Melphalan—Pruritus—Etoposide—lung cancer	0.00016	0.000329	CcSEcCtD
Melphalan—SLC22A3—Metabolism—RRM1—lung cancer	0.000159	0.00104	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA3—lung cancer	0.000159	0.00104	CbGpPWpGaD
Melphalan—Asthenia—Paclitaxel—lung cancer	0.000159	0.000328	CcSEcCtD
Melphalan—Nausea—Gemcitabine—lung cancer	0.000157	0.000324	CcSEcCtD
Melphalan—Vomiting—Cisplatin—lung cancer	0.000157	0.000323	CcSEcCtD
Melphalan—Pruritus—Paclitaxel—lung cancer	0.000157	0.000323	CcSEcCtD
Melphalan—Rash—Cisplatin—lung cancer	0.000156	0.00032	CcSEcCtD
Melphalan—Dermatitis—Cisplatin—lung cancer	0.000155	0.00032	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—lung cancer	0.000155	0.000319	CcSEcCtD
Melphalan—Anaemia—Methotrexate—lung cancer	0.000153	0.000316	CcSEcCtD
Melphalan—Flushing—Doxorubicin—lung cancer	0.000153	0.000315	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AVP—lung cancer	0.000152	0.00099	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—EP300—lung cancer	0.000152	0.00099	CbGpPWpGaD
Melphalan—Diarrhoea—Paclitaxel—lung cancer	0.000152	0.000312	CcSEcCtD
Melphalan—SLC22A3—Metabolism—B4GALT5—lung cancer	0.00015	0.000976	CbGpPWpGaD
Melphalan—Immune system disorder—Doxorubicin—lung cancer	0.000149	0.000307	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—lung cancer	0.000149	0.000306	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—lung cancer	0.000149	0.000306	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SRC—lung cancer	0.000148	0.000962	CbGpPWpGaD
Melphalan—Arrhythmia—Doxorubicin—lung cancer	0.000147	0.000304	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000147	0.000959	CbGpPWpGaD
Melphalan—Nausea—Cisplatin—lung cancer	0.000147	0.000302	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—lung cancer	0.000146	0.0003	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTA4—lung cancer	0.000146	0.000949	CbGpPWpGaD
Melphalan—Cough—Methotrexate—lung cancer	0.000145	0.000298	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—VEGFA—lung cancer	0.000144	0.000937	CbGpPWpGaD
Melphalan—Convulsion—Methotrexate—lung cancer	0.000144	0.000296	CcSEcCtD
Melphalan—Vomiting—Etoposide—lung cancer	0.000144	0.000296	CcSEcCtD
Melphalan—Rash—Etoposide—lung cancer	0.000143	0.000294	CcSEcCtD
Melphalan—Dermatitis—Etoposide—lung cancer	0.000142	0.000293	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—NRAS—lung cancer	0.000142	0.000926	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTA2—lung cancer	0.000142	0.000925	CbGpPWpGaD
Melphalan—Myalgia—Methotrexate—lung cancer	0.000141	0.000291	CcSEcCtD
Melphalan—Chest pain—Methotrexate—lung cancer	0.000141	0.000291	CcSEcCtD
Melphalan—Vomiting—Paclitaxel—lung cancer	0.000141	0.00029	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00014	0.000289	CcSEcCtD
Melphalan—Rash—Paclitaxel—lung cancer	0.00014	0.000288	CcSEcCtD
Melphalan—Dermatitis—Paclitaxel—lung cancer	0.00014	0.000288	CcSEcCtD
Melphalan—Hypersensitivity—Docetaxel—lung cancer	0.000138	0.000285	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTA1—lung cancer	0.000137	0.000893	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK3—lung cancer	0.000136	0.000887	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCC3—lung cancer	0.000136	0.000883	CbGpPWpGaD
Melphalan—Anaphylactic shock—Methotrexate—lung cancer	0.000135	0.000279	CcSEcCtD
Melphalan—Asthenia—Docetaxel—lung cancer	0.000135	0.000278	CcSEcCtD
Melphalan—Infection—Methotrexate—lung cancer	0.000135	0.000277	CcSEcCtD
Melphalan—Nausea—Etoposide—lung cancer	0.000134	0.000277	CcSEcCtD
Melphalan—Pruritus—Docetaxel—lung cancer	0.000133	0.000274	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—lung cancer	0.000133	0.000273	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—lung cancer	0.000133	0.000273	CcSEcCtD
Melphalan—Nausea—Paclitaxel—lung cancer	0.000132	0.000271	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—lung cancer	0.000132	0.000271	CcSEcCtD
Melphalan—SLC22A3—Metabolism—AKR1C1—lung cancer	0.000131	0.000855	CbGpPWpGaD
Melphalan—Anorexia—Methotrexate—lung cancer	0.000129	0.000266	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—lung cancer	0.000129	0.000265	CcSEcCtD
Melphalan—Diarrhoea—Docetaxel—lung cancer	0.000129	0.000265	CcSEcCtD
Melphalan—SLC22A3—Metabolism—UGT1A1—lung cancer	0.000127	0.00083	CbGpPWpGaD
Melphalan—Hypotension—Methotrexate—lung cancer	0.000127	0.000261	CcSEcCtD
Melphalan—Cough—Doxorubicin—lung cancer	0.000125	0.000258	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—lung cancer	0.000124	0.000256	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000123	0.000254	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GNG11—lung cancer	0.000123	0.0008	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KRAS—lung cancer	0.000122	0.000797	CbGpPWpGaD
Melphalan—Myalgia—Doxorubicin—lung cancer	0.000122	0.000252	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—lung cancer	0.000122	0.000252	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—lung cancer	0.000122	0.00025	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000121	0.00025	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—lung cancer	0.000121	0.000249	CcSEcCtD
Melphalan—Vomiting—Docetaxel—lung cancer	0.000119	0.000246	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—lung cancer	0.000119	0.000245	CcSEcCtD
Melphalan—Rash—Docetaxel—lung cancer	0.000118	0.000244	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—lung cancer	0.000118	0.000244	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—lung cancer	0.000118	0.000242	CcSEcCtD
Melphalan—Oedema—Doxorubicin—lung cancer	0.000117	0.000241	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—lung cancer	0.000117	0.000241	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ALDOA—lung cancer	0.000117	0.000762	CbGpPWpGaD
Melphalan—Gastrointestinal disorder—Methotrexate—lung cancer	0.000117	0.000241	CcSEcCtD
Melphalan—Fatigue—Methotrexate—lung cancer	0.000117	0.00024	CcSEcCtD
Melphalan—Infection—Doxorubicin—lung cancer	0.000116	0.00024	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000116	0.000757	CbGpPWpGaD
Melphalan—Pain—Methotrexate—lung cancer	0.000116	0.000238	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—lung cancer	0.000115	0.000236	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—lung cancer	0.000114	0.000236	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—lung cancer	0.000114	0.000235	CcSEcCtD
Melphalan—SLC22A3—Metabolism—NCOA3—lung cancer	0.000114	0.00074	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CA—lung cancer	0.000112	0.000732	CbGpPWpGaD
Melphalan—Anorexia—Doxorubicin—lung cancer	0.000112	0.00023	CcSEcCtD
Melphalan—Nausea—Docetaxel—lung cancer	0.000112	0.00023	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ADCY1—lung cancer	0.00011	0.000719	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG2—lung cancer	0.00011	0.000719	CbGpPWpGaD
Melphalan—Hypotension—Doxorubicin—lung cancer	0.00011	0.000226	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—TP53—lung cancer	0.000109	0.000708	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ENO2—lung cancer	0.000108	0.000706	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HPGDS—lung cancer	0.000108	0.000706	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPP2R1B—lung cancer	0.000108	0.000701	CbGpPWpGaD
Melphalan—Urticaria—Methotrexate—lung cancer	0.000108	0.000222	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000107	0.00022	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—lung cancer	0.000105	0.000217	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTT1—lung cancer	0.000105	0.000684	CbGpPWpGaD
Melphalan—Dyspnoea—Doxorubicin—lung cancer	0.000105	0.000215	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—HRAS—lung cancer	0.000104	0.000677	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCLC—lung cancer	0.000104	0.000676	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2A6—lung cancer	0.000104	0.000676	CbGpPWpGaD
Melphalan—Dyspepsia—Doxorubicin—lung cancer	0.000103	0.000213	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—lung cancer	0.000102	0.00021	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000101	0.000208	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—lung cancer	0.000101	0.000208	CcSEcCtD
Melphalan—Pain—Doxorubicin—lung cancer	0.0001	0.000207	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—lung cancer	9.98e-05	0.000205	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ENO1—lung cancer	9.85e-05	0.000641	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CREBBP—lung cancer	9.84e-05	0.000641	CbGpPWpGaD
Melphalan—Asthenia—Methotrexate—lung cancer	9.72e-05	0.0002	CcSEcCtD
Melphalan—Pruritus—Methotrexate—lung cancer	9.58e-05	0.000197	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—lung cancer	9.31e-05	0.000192	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—lung cancer	9.26e-05	0.000191	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—lung cancer	9.21e-05	0.0006	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—lung cancer	9.18e-05	0.000598	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2E1—lung cancer	8.83e-05	0.000575	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NQO1—lung cancer	8.73e-05	0.000569	CbGpPWpGaD
Melphalan—Hypersensitivity—Doxorubicin—lung cancer	8.64e-05	0.000178	CcSEcCtD
Melphalan—Vomiting—Methotrexate—lung cancer	8.61e-05	0.000177	CcSEcCtD
Melphalan—Rash—Methotrexate—lung cancer	8.54e-05	0.000176	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—lung cancer	8.53e-05	0.000176	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—lung cancer	8.41e-05	0.000173	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—RAF1—lung cancer	8.33e-05	0.000542	CbGpPWpGaD
Melphalan—Pruritus—Doxorubicin—lung cancer	8.3e-05	0.000171	CcSEcCtD
Melphalan—Nausea—Methotrexate—lung cancer	8.04e-05	0.000166	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—lung cancer	8.02e-05	0.000165	CcSEcCtD
Melphalan—SLC22A3—Metabolism—STK11—lung cancer	7.87e-05	0.000513	CbGpPWpGaD
Melphalan—Vomiting—Doxorubicin—lung cancer	7.45e-05	0.000154	CcSEcCtD
Melphalan—Rash—Doxorubicin—lung cancer	7.39e-05	0.000152	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—lung cancer	7.39e-05	0.000152	CcSEcCtD
Melphalan—SLC22A3—Metabolism—GSTP1—lung cancer	7.28e-05	0.000474	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAT—lung cancer	7.09e-05	0.000462	CbGpPWpGaD
Melphalan—Nausea—Doxorubicin—lung cancer	6.96e-05	0.000143	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ABCB1—lung cancer	6.89e-05	0.000449	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TYMS—lung cancer	6.77e-05	0.000441	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—lung cancer	6.69e-05	0.000436	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP1A1—lung cancer	6.35e-05	0.000413	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ERCC2—lung cancer	6.29e-05	0.00041	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA1—lung cancer	5.44e-05	0.000355	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CG—lung cancer	4.97e-05	0.000324	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—POMC—lung cancer	4.73e-05	0.000308	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CREBBP—lung cancer	4.61e-05	0.0003	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CD—lung cancer	4.37e-05	0.000285	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—lung cancer	4.31e-05	0.000281	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CB—lung cancer	3.81e-05	0.000248	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—lung cancer	3.77e-05	0.000246	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTEN—lung cancer	3.29e-05	0.000214	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—EP300—lung cancer	3.14e-05	0.000204	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CA—lung cancer	2.32e-05	0.000151	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—lung cancer	1.9e-05	0.000124	CbGpPWpGaD
